Has Abiola Izekor received payments from drug or device companies?

Yes. Drug and device makers reported $754 in general payments to Abiola Izekor across 50 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abiola Izekor did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abiola Izekor come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abiola Izekor

Psychiatric/Mental Health · San Francisco, CANPI 1194455741

Payments from drug & device makers

$754in general payments, 2019–2025

Across 50 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$177
Otsuka America Pharmaceutical, Inc.$140
AbbVie$127
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$101
Takeda Pharmaceuticals U.S.A., Inc.$85
Johnson & Johnson$23
plus $101 from 5 others

What the payments were for

Food & beverage$74699%
Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	21	$177
Otsuka America Pharmaceutical, Inc.	7	$140
AbbVie	7	$127
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$101
Takeda Pharmaceuticals U.S.A., Inc.	5	$85
Johnson & Johnson	1	$23
Vertical Pharmaceuticals, LLC	1	$23
Lundbeck LLC	1	$21
Tris Pharma Inc	1	$20
Teva Pharmaceuticals USA, Inc.	1	$19
Collegium Pharmaceutical, Inc.	1	$17

How this compares

$754 in reported general payments places this provider in the 60th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California →

Medicare billing

Part B allowed, 2024

$507,363

Medicare patients

278

Services billed

7,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
NuedextaDextromethorphan Hbr/Quinidine	28	$13,317
Aripiprazole	83	$11,024
Divalproex Sodium	116	$5,456
Duloxetine Hcl	116	$4,887
Quetiapine Fumarate	148	$2,798
Sertraline Hcl	206	$2,786
Trazodone Hcl	219	$2,716
Buspirone Hcl	107	$2,651
Mirtazapine	89	$2,569
Bupropion XlBupropion Hcl	93	$2,463
Memantine Hcl	102	$1,877
Oxcarbazepine	40	$1,529
Hydroxyzine Hcl	51	$1,405
Venlafaxine Hcl ErVenlafaxine Hcl	62	$1,376
Escitalopram Oxalate	130	$1,376

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in San Francisco

Charles WilliamsonSan Francisco$10K
Carey MartinMillbrae$745K
Liberty MaciasRedlands$288K
Joshua BurgettSacramento$239K
Jovita Ezirim-SalamialofojeLos Angeles$162K
Angie-Kolleen TanThousand Oaks$159K
Thy LamVista$121K
David OhIrvine$72K
Samantha PerkinsAnaheim$49K
Yvette ElpidioOrange$43K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →